Cannabis Suisse Corp (CSUI)

Healthcare | Drug Manufacturers Specialty Generic
Income Statement (Quarterly) 2025-08-31 2025-02-28 2024-11-30 2024-08-31
Revenue 0 7,500 7,500 7,500
Cost of Revenue 0 7,356 7,356 7,356
Gross Profit 0 144 144 144
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 83,474 65,871 91,392 73,922
Operating Expenses 84,535 65,871 91,392 73,922
Operating Income 0 -65,727 -91,248 -74,839
Interest Expense 16,297 15,943 16,120 14,849
Income Before Tax 13,907 29,515 5,062 -535,086
Income Tax Expense 0 0 0 0
Net Income 13,907 29,515 5,062 -535,086
Per Share
EPS 0.00 0.00 0.00 -0.01
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Revenue 22,500 30,000 10,000 7,770 50,850
Cost of Revenue 22,068 30,067 9,166 1,734 102,648
Gross Profit 432 -67 834 6,036 -51,798
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 284,201 252,626 339,272 161,192 297,006
Operating Expenses 284,201 256,870 343,516 163,191 306,655
Operating Income -283,769 -257,000 -342,682 -157,155 -358,453
Interest Expense 63,208 26,802 8,865 63,579 60,344
Income Before Tax -456,142 -1,265,000 -351,547 -187,890 -410,894
Income Tax Expense 0 0 -163,651 30,735 0
Net Income -456,142 -1,265,000 -351,547 -218,625 -410,894
Per Share
EPS -0.01 -0.03 -0.01 -0.01 -0.01
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Assets
Cash and Cash Equivalents 2,850 28,562 -206,959 0
Short Term Investments 0 0 0 0
Net Receivables 0 0 0 0
Inventory 0 0 0 0
Total Current Assets 106,841 168,902 4,699 0
Property Plant Equipment 528,234 649,705 341,604 0
Goodwill and Intangibles 0 0 0 0
Total Assets 635,075 818,607 346,303 0
Liabilities
Account Payables 7,775 4,304 10,770 883
Short Term Debt 240,137 260,157 135,000 135,000
Total Current Liabilities 325,520 381,000 333,791 274,092
Long Term Debt 2,111,527 1,861,453 341,959 0
Total Liabilities 2,437,047 2,242,453 675,750 274,092
Shareholders Equity
Retained Earnings -3,057,046 -2,678,920 -1,414,291 -1,062,744
Total Shareholders Equity -1,801,972 -1,423,846 -329,447 -274,092
Balance Sheet (Annual) 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Assets
Cash and Cash Equivalents 2,850 28,562 -206,959 0 0
Short Term Investments 0 0 0 0 0
Net Receivables 0 0 0 0 0
Inventory 0 0 0 0 1,734
Total Current Assets 106,841 168,902 4,699 0 2,184
Property Plant Equipment 528,234 649,705 341,604 0 4,383
Goodwill and Intangibles 0 0 0 0 0
Total Assets 635,075 818,607 346,303 0 6,567
Liabilities
Account Payables 7,775 4,304 10,770 883 0
Short Term Debt 240,137 260,157 135,000 135,000 67,213
Total Current Liabilities 325,520 381,000 333,791 274,092 194,061
Long Term Debt 2,111,527 1,861,453 341,959 0 0
Total Liabilities 2,437,047 2,242,453 675,750 274,092 194,061
Shareholders Equity
Retained Earnings -3,057,046 -2,678,920 -1,414,291 -1,062,744 -874,854
Total Shareholders Equity -1,801,972 -1,423,846 -329,447 -274,092 -187,494
Cash Flow Statement (Quarterly) 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Operating Activities
Net Income -456,142 -1,264,629 -351,547 -187,890
Depreciation & Amortization 4,244 4,244 4,244 1,999
Stock Based Compensation 0 20,000 124,000 0
Change in Working Capital 125,580 44,644 15,135 123,067
Operating Cash Flow -45,112 -45,637 -163,960 -32,089
Investing Activities
Capital Expenditure 0 -3 0 0
Investments 0 -3 0 0
Investing Cash Flow 0 0 0 0
Financing Activities
Debt Repayment 0 0 -135,000 0
Common Stock Issued/Repurchased 0 20,000 0 0
Dividends Paid 0 0 0 0
Financing Cash Flow 19,400 74,000 164,159 32,089
Summary
Free Cash Flow -45,112 -45,637 -163,960 -32,089
Net Change in Cash -25,712 28,363 199 0
Cash Flow Statement (Annual) 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Operating Activities
Net Income -456,142 -1,264,629 -351,547 -187,890 -419,372
Depreciation & Amortization 4,244 4,244 4,244 1,999 22,422
Stock Based Compensation 0 20,000 124,000 0 0
Change in Working Capital 125,580 44,644 15,135 123,067 135,076
Operating Cash Flow -45,112 -45,637 -163,960 -32,089 -130,606
Investing Activities
Capital Expenditure 0 -3 0 0 0
Investments 0 -3 0 0 0
Investing Cash Flow 0 0 0 0 0
Financing Activities
Debt Repayment 0 0 -135,000 0 0
Common Stock Issued/Repurchased 0 20,000 0 0 0
Dividends Paid 0 0 0 0 0
Financing Cash Flow 19,400 74,000 164,159 32,089 130,601
Summary
Free Cash Flow -45,112 -45,637 -163,960 -32,089 -130,606
Net Change in Cash -25,712 28,363 199 0 130,601